TY - JOUR
T1 - Differential efficacy of DOTAP enantiomers for siRNA delivery in vitro
AU - Terp, Megan Cavanaugh
AU - Bauer, Finn
AU - Sugimoto, Yasuro
AU - Yu, Bo
AU - Brueggemeier, Robert W.
AU - Lee, L. James
AU - Lee, Robert J.
N1 - Funding Information:
This work was supported in part by NSF grants DGE0221678 , EEC-0425626 , EEC-0914790 , and EEC-0425626 to L. James Lee and DOD grant W81XWH-08-1-0610 to Robert J. Lee. The authors thank Yeshayahu Talmon, Sharon Golan, Ellina Kesselman and Judith Schmidt at the Technion – Israel Institute of Technology for their TEM training and Yun Wu for her assistance on confocal sample preparation.
PY - 2012/7/1
Y1 - 2012/7/1
N2 - DOTAP, as a racemic mixture, is a cationic lipid and a widely used transfection reagent. In this study, the effect of DOTAP's stereochemical structure on transfection efficiency was evaluated in vitro. Racemic and enantiomerically pure DOTAP were used in lipoplex formulations to deliver siRNA to MCF-7 cells, targeting the aromatase enzyme. At the 50 nM siRNA concentration and lipid-to-RNA charge ratios of 4 and 5, the R enantiomer of DOTAP was found to perform better than either the S- or the racemic agent. In addition, at 10 nM siRNA concentration and a charge ratio of 3, the R- lipoplex formulation silenced aromatase by ∼50% whereas the S and racemic formulations caused no significant target downregulation. Differences in lipid packing were modeled using membrane simulations. The results showed that, when combined with cholesterol, pure R-DOTAP and S-DOTAP enantiomers had 105% and 115% of lipid density relative to racemic DOTAP, respectively. These findings suggest an important role of lipid chirality in future development of lipid based siRNA delivery systems.
AB - DOTAP, as a racemic mixture, is a cationic lipid and a widely used transfection reagent. In this study, the effect of DOTAP's stereochemical structure on transfection efficiency was evaluated in vitro. Racemic and enantiomerically pure DOTAP were used in lipoplex formulations to deliver siRNA to MCF-7 cells, targeting the aromatase enzyme. At the 50 nM siRNA concentration and lipid-to-RNA charge ratios of 4 and 5, the R enantiomer of DOTAP was found to perform better than either the S- or the racemic agent. In addition, at 10 nM siRNA concentration and a charge ratio of 3, the R- lipoplex formulation silenced aromatase by ∼50% whereas the S and racemic formulations caused no significant target downregulation. Differences in lipid packing were modeled using membrane simulations. The results showed that, when combined with cholesterol, pure R-DOTAP and S-DOTAP enantiomers had 105% and 115% of lipid density relative to racemic DOTAP, respectively. These findings suggest an important role of lipid chirality in future development of lipid based siRNA delivery systems.
KW - Aromatase
KW - DOTAP
KW - Enantiomer
KW - Lipoplex
KW - Modeling
KW - siRNA
UR - http://www.scopus.com/inward/record.url?scp=84860771690&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2012.04.017
DO - 10.1016/j.ijpharm.2012.04.017
M3 - Article
C2 - 22525086
AN - SCOPUS:84860771690
SN - 0378-5173
VL - 430
SP - 328
EP - 334
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
IS - 1-2
ER -